These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6342020)

  • 1. The potential for administrative cost savings under a capitation reimbursement system for prescription drugs.
    Standridge CR; Capettini R; Myers GM; Rao NB
    Public Health; 1983 Jan; 97(1):46-58. PubMed ID: 6342020
    [No Abstract]   [Full Text] [Related]  

  • 2. A preimplementation assessment of a capitation reimbursement system using simulation.
    Standridge CR; Fisher WP; Tsai J
    J Med Syst; 1983 Feb; 7(1):43-59. PubMed ID: 6345708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Capitation payment for pharmacy services. I. Impact on drug use and pharmacist dispensing behavior.
    Yesalis CE; Lipson DP; Norwood GJ; Helling DK; Burmeister LF; Jones ME; Fisher WP
    Med Care; 1984 Aug; 22(8):737-45. PubMed ID: 6381921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medicaid prescription drug coverage: state efforts to control costs.
    Gencarelli DM
    NHPF Issue Brief; 2003 May; (790):1-17. PubMed ID: 12751504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacists' views of an experience in capitation reimbursement under the Iowa Medicaid drug program.
    Cirn JT
    Contemp Pharm Pract; 1980; 3(3):180-8. PubMed ID: 10297946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use and costs under the Iowa capitation drug program.
    Yesalis CE; Norwood GJ; Lipson DP; Helling DK; Burmeister LF; Fisher WP
    Health Care Financ Rev; 1981 Sep; 3(1):127-36. PubMed ID: 10309472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Capitation payment for pharmacy services: impact on generic substitution.
    Yesalis CE; Norwood GJ; Lipson DP; Helling DK; Fisher WP; Burmeister LF
    Med Care; 1980 Aug; 18(8):816-28. PubMed ID: 6997648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Capitation payment for pharmacy services. II. Impact on costs.
    Yesalis CE; Norwood GJ; Helling DK; Lipson DP; Mahrenholz RJ; Burmeister LF; Jones ME; Fisher WP
    Med Care; 1984 Aug; 22(8):746-54. PubMed ID: 6381922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Capitation payment for medicaid pharmacy services: impact on non-medicaid prescriptions.
    Lipson DP; Yesalis CE; Kohout FJ; Norwood GJ
    Med Care; 1981 Mar; 19(3):342-53. PubMed ID: 7012466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of capitation payment for pharmacy services on pharmacist-dispensing and physician-prescribing behavior: I. Prescription quantity and dose analysis.
    Helling DK; Yesalis CE; Norwood GJ; Burmeister LF; Lipson DP; Fisher WP; Jones ME
    Drug Intell Clin Pharm; 1981; 15(7-8):581-9. PubMed ID: 7018872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient counseling in community pharmacy and its relationship with prescription payment methods and practice settings.
    Raisch DW
    Ann Pharmacother; 1993 Oct; 27(10):1173-9. PubMed ID: 8251681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reimbursement by capitation: it's new, controversial, and strengthens incentive.
    Norwood GJ; Yesalis C; Lipson D; Johnson N
    Am Pharm; 1979 Jan; 19(1):37-40. PubMed ID: 364969
    [No Abstract]   [Full Text] [Related]  

  • 13. Estimating pharmacy level prescription drug acquisition costs for third-party reimbursement.
    Kreling DH; Kirk KW
    Med Care; 1986 Jul; 24(7):590-600. PubMed ID: 3523065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Making sense of outpatient pharmacy management. How to control pharmacy costs while delivering quality care.
    Olson-Garewal JK
    Postgrad Med; 2001 Jul; 110(1):7-10. PubMed ID: 11467044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prescription charges in rural practices: difficulties encountered in prescribing.
    Bills J
    N Z Med J; 1989 Apr; 102(866):202. PubMed ID: 2710459
    [No Abstract]   [Full Text] [Related]  

  • 16. 'Mid-level providers' can ease your capitation crunch.
    Kelley T
    Manag Care; 1994 Jul; 3(7):19-24, 26. PubMed ID: 10141795
    [No Abstract]   [Full Text] [Related]  

  • 17. Differences in the cost of antidepressants across state Medicaid programs.
    Kelton CM; Rebelein RP; Heaton PC; Ferrand Y; Guo JJ
    J Ment Health Policy Econ; 2008 Mar; 11(1):33-47. PubMed ID: 18424875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Third party prescription programs: cost containment issues and strategies.
    Richards JW
    Am Pharm; 1985 Jul; NS25(7):28-35. PubMed ID: 4036802
    [No Abstract]   [Full Text] [Related]  

  • 19. Blockbuster drugs coming off patent: will cap contracts benefit?
    Capitation Manag Rep; 2002 Apr; 9(4):56-8, 49. PubMed ID: 12004736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Financial impact of a pharmacist-managed medication refill clinic.
    Nelson LA; Downs GE; Cummings DM; Seaman JJ
    Mil Med; 1984 May; 149(5):254-6. PubMed ID: 6427688
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.